New York State Common Retirement Fund’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$188K Hold
11,757
﹤0.01% 2394
2026
Q1
$218K Hold
11,757
﹤0.01% 2206
2025
Q4
$183K Buy
+11,757
New +$168K ﹤0.01% 2334
2024
Q3
Sell
-9,368
Closed -$121K 3328
2024
Q2
$121K Hold
9,368
﹤0.01% 2655
2024
Q1
$130K Hold
9,368
﹤0.01% 2632
2023
Q4
$134K Hold
9,368
﹤0.01% 2618
2023
Q3
$145K Buy
+9,368
New +$145K ﹤0.01% 2563

Other funds holding TAK

New York State Common Retirement Fund's TAK Position: Q2 2026 in Review

New York State Common Retirement Fund held its Takeda Pharmaceutical (TAK) position steady in Q2 2026 at 11,757 shares worth $188K. The position accounts for ﹤0.01% of the portfolio, ranked #2394.

New York State Common Retirement Fund first reported a position in TAK in Q3 2023 and has held it in 7 quarters since. The position peaked at $218K in Q1 2026. 177 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • New York State Common Retirement Fund held 11,757 shares of Takeda Pharmaceutical worth $188K as of Q2 2026.
  • New York State Common Retirement Fund left its Takeda Pharmaceutical share count unchanged in Q2 2026.
  • Takeda Pharmaceutical made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2394 holding.
  • New York State Common Retirement Fund first reported a position in Takeda Pharmaceutical in Q3 2023 and has held it in 7 quarters since.
  • New York State Common Retirement Fund's Takeda Pharmaceutical position peaked at $218K in Q1 2026.
  • 177 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.